Internal Medicine News‘Unprecedented’ 3-year sustained survival with lung cancer combo treatmentOctober 4, 2021Oncology
Internal Medicine NewsNovel virus targeting deadly brain tumors shows early promiseOctober 1, 2021Oncology
Internal Medicine NewsNovel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancerSeptember 30, 2021Breast CancerWomen's HealthOncology
Internal Medicine NewsTreatment shows 'important improvements' in triple-negative breast cancerSeptember 30, 2021Breast CancerOncology
Internal Medicine NewsResponse to preop immunotherapy predicts survival in early NSCLCSeptember 30, 2021Oncology
Internal Medicine NewsFDA approval for tisotumab vedotin in advanced cervical cancerSeptember 30, 2021OncologyWomen's Health
Internal Medicine NewsBetter survival with extended letrozole in early-stage breast cancerSeptember 29, 2021Breast CancerOncology
Internal Medicine NewsStudies confirm survival benefit with postchemoradiotherapy consolidation in NSCLCSeptember 29, 2021Oncology
Internal Medicine NewsOnce daily poziotinib shows efficacy in non–small cell lung cancerSeptember 28, 2021Oncology
Internal Medicine NewsAtezolizumab plus chemotherapy superior to best supportive care in early lung cancerSeptember 28, 2021Oncology
Internal Medicine NewsStudy supports chemotherapy with immunotherapy for some never-smokers with lung cancerSeptember 28, 2021Oncology
Internal Medicine News‘Locker room talk’ about death: Time for oncologists to stopSeptember 24, 2021OncologyMixed Topics
Internal Medicine NewsFirst-line bevacizumab-osimertinib disappoint in EGFR-mutant NSCLCSeptember 24, 2021Oncology
Internal Medicine NewsCombination treatment shows promise for men with advanced prostate cancerSeptember 24, 2021Oncology
Internal Medicine NewsLong COVID appears to ‘impair’ survival in cancer patientsSeptember 23, 2021COVID-19 UpdatesOncology
